CALMITANE 250MG
Natural health product licensed in Canada
- Licence holder
- Laboratoire Bionatus Pharmacognosique Inc.
- NPN or DIN-HM
- 80100430
- Status
- Active licence
- Licence date
- 20 May 2020
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Valeriana officinalis Source : Racine Potency : 0.8 % Sesquiterpenic acids | 250 mg | Not calculated |
Non-medicinal ingredients
Macrogol 400, PVP, Cellulose microcristalline, Macrogol 8 000, Hydroxypropylméthylcellulose, Dioxyde de silicium colloïdal, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Comprimé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
(Traditionally) used in Herbal Medicine to help relieve restlessness and/or nervousness (calmative). (Traditionally used in Herbal Medicine as a) sleep aid/(to) help(s) to promote sleep.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
This tablet should not be partied or masticated. Avoid taking with alcohol or products that cause drowsiness. Consult a health care practitioner/health care provider/health care professional/doctor/ physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists continuously for more than 4 weeks (chronic insomnia).
- Effets indésirables connus
Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness.
Source
Official Health Canada record, licence 80100430
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.